Improved Synthesis and In Vitro Evaluation of an Aptamer Ribosomal Toxin Conjugate

Linsley Kelly1, Christina Kratschmer1, Keith E Maier1

  • 1Department of Biochemistry, Albert Einstein College of Medicine , Bronx, New York City, New York.

Insights

Researchers developed a streamlined method for creating aptamer-toxin conjugates for cancer therapy. This new approach uses a minimized aptamer for efficient delivery of toxins like gelonin to prostate cancer cells.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Antibody-toxin conjugates (immunotoxins) show promise in cancer treatment but face challenges like bulkiness and immunogenicity.
  • Previous work utilized a full-length aptamer (A9) to deliver recombinant gelonin (rGel) to prostate-specific membrane antigen (PSMA)-expressing cells.
  • A need exists for more streamlined and scalable methods for generating aptamer-toxin conjugates.

Purpose of the Study:

  • To develop a simplified and scalable method for generating aptamer-rGel conjugates.
  • To evaluate the binding specificity and toxicity of the novel aptamer-toxin conjugate.
  • To assess the in vitro stability of the conjugate for potential in vivo applications.

Main Methods:

  • Chemically synthesized a minimized A9 aptamer with a 5' terminal thiol.
  • Generated aptamer-toxin conjugates using a reducible disulfide linkage.
  • Assessed conjugate binding specificity and cytotoxicity on PSMA(+) LNCaP prostate cancer cells.
  • Performed serum stability analysis of the conjugate in mouse serum.

Main Results:

  • The A9.min-rGel conjugate demonstrated specific binding and toxicity against PSMA(+) LNCaP cells with an IC50 of approximately 60 nM.
  • The conjugate exhibited a half-life (t1/2) of approximately 4 hours in mouse serum.
  • The streamlined chemical synthesis facilitated large-scale production of the aptamer-toxin conjugate.

Conclusions:

  • A minimized aptamer approach offers an efficient and scalable method for producing aptamer-toxin conjugates.
  • The A9.min-rGel conjugate shows potential for targeted cancer therapy due to its specificity and stability.
  • This strategy paves the way for further in vivo studies and development of novel targeted cancer treatments.

Related Concept Videos

RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.5K
Ribosome Profiling02:24

Ribosome Profiling

Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
4.3K
Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
15.4K
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
15
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.2K